NASDAQ:PIII
P3 Health Partners Inc.
P3 Health Partners Inc.'s revenue fell 2.8% in fiscal 2025 to $1.5B while operating margin rose to −18.5%. The diluted share count rose 11.2%.Summary generated from P3 Health Partners Inc.'s SEC filings. Latest annual report filed Mar 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$1.5B
Revenue growth−2.8%
Revenue, 5-yr CAGR+58.6%
Gross marginn/a
Operating margin−18.5%
Net margin−10.1%
ROIC−220.0%
Return on equityn/a
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+11.2%
Financials
| Item | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 491 | 1,049 | 1,266 | 1,500 | 1,459 |
| Operating income | −29 | −1,561 | −168 | −321 | −270 |
| Net income | −31 | −270 | −58 | −136 | −148 |
| Free cash flow | −28 | −128 | −78 | −110 | n/a |
Recent filings
- 8-KEntry into a material agreement
Sep 11, 2026 - 4Insider transaction report
Aug 14, 2026 - 4Insider transaction report
Aug 12, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 10, 2026 - 8-KResults of operations and financial condition
Aug 10, 2026 - 8-KEntry into a material agreement
Jul 6, 2026 - 8-KResults of a shareholder vote
Jun 10, 2026 - 8-KNotice of delisting or listing-rule failure
May 26, 2026